BROOKLYN IMMUNOTHERAPEUTICS INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 19th, 2021 • Brooklyn ImmunoTherapeutics, Inc. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made as of July 16, 2021, by and among Brooklyn ImmunoTherapeutics, Inc., a Delaware corporation (“Brooklyn”), and the individuals and entities listed on Schedule I to this Agreement, (together with any subsequent securities holders, or transferees, who become parties to this Agreement as “Holders” pursuant to Section 9, the “Holders” and each individually a “Holder”). Capitalized terms used herein without definition shall have the respective meanings ascribed to such terms in the Acquisition Agreement (defined below).
AGREEMENT AND PLAN OF ACQUISITIONAgreement and Plan of Acquisition • July 19th, 2021 • Brooklyn ImmunoTherapeutics, Inc. • Pharmaceutical preparations • Delaware
This Agreement and Plan of Acquisition (this “Agreement”) is made and entered into as of July 16, 2021, by and among Brooklyn ImmunoTherapeutics, Inc., a Delaware corporation (“Brooklyn”), Brooklyn Acquisition Sub, Inc., a Delaware corporation (“Merger Sub”), Novellus LLC, a Delaware limited liability company ( “Seller”), Novellus, Inc., a Delaware corporation ( “Parent,” and collectively with Brooklyn, Merger Sub and Seller, the “Parties”) and Matthew Angel, in his capacity as Sellers’ Representative. Certain capitalized terms used in this Agreement shall have the meanings set forth in Exhibit A.
